The fascinating history of the importance of I... - CLL Support
The fascinating history of the importance of IGHV mutation status in CLL prognosis and treatment
You need to be a member of this community to see this post.
Read more about...
- Chemotherapy
- Vaccination
- Immunoglobulin
- Radioactive iodine
- Immunoglobulin M
- Amino acids
- FCR
- Chronic leukaemia
- Targeted therapy
62 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Median PFS for FCR treated CLL patients with IGHV-M was 14.6 years vs 4.2 years for patients with IGHV-UM. V+O and I+R look to be superior
An update of the long-term follow-up results from the original 300-patient FCR (fludarabine,...
Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in CLL? - Dr Keating
A complex but interesting read
Acta Haematol August 2018;140:51–54
The immunoglobulin heavy chain...
Mutated and unmutated cll for dummies
When told I had chronic lymphocytic leukemia (cll) four years ago, all I heard was "leukemia"....
Relative risk for secondary bone marrow cancer within 5 years after initial CLL chemoimmunotherapy treatment (typically BR or FCR)
In countries where targeted therapies ('brutinibs, venetoclax, obinutuzumab/rituximab) are now...
Does CLL begin neonatal?
Remember ...it is a long way from mouse to man, but an interesting study...
...
A...
Related Posts
- Question - how many different varieties of antibodies can B-cells make? Hint - it's hypermutation (IGHV mutation) that makes it possible
- Potential Early Drivers of Disease in Treatment-Naive CLL Identified
Five-year results for the iFCG regimen: first-line treatment of CLL patients with mutated IGHV and without del(17p)/TP53 mutation- NOTCH1 mutational status - high risk of transformation and poor outcome
Who is Getting the IGHV (formerly known as IgVH) Mutational Status Tests in UK?
